{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:13:12Z","timestamp":1790107992474,"version":"4.0.1"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:p>Depression and schizophrenia are 2 serious mental disorders. Their effective treatment is an urgent medical and social problem at present. Drug treatment is the basic measure to improve mental disorders, especially serious mental disorders. However, the side effects of traditional antipsychotic drugs cannot be avoided. Surprisingly, in recent years, it has been found that nitric oxide (NO), carbon monoxide (CO), hydrogen sulfide (H<jats:sub>2<\/jats:sub>S) and hydrogen (H<jats:sub>2<\/jats:sub>) can regulate corresponding signal pathways to treat mental diseases in animal models. More importantly, as gas signal molecules, they will not bring toxicity and side effects after metabolism. Therefore, in this review, we analyzed the effects of gas on depression and schizophrenia through endogenous gas generation and external gas delivery strategies in some animal models. Endogenous gas generation strategy: summarized the therapeutic mechanism of gas signaling molecules on depression and schizophrenia, and listed the main ways to inhibit or stimulate gas generation. External gas delivery strategy: The common external stimuli-responsive gasotransmitter prodrugs and some study of these prodrugs in the treatment of depression and schizophrenia are summarized. We also analyzed the prospects of nano-gas carrier in the treatment of depression and schizophrenia. Through this review, we hope to provide guidance for treating depression and schizophrenia by regulating relevant gas signal pathways, and provide reference for developing safe and effective drugs for treating mental disorders by summarizing exogenous gas drugs.<\/jats:p>","DOI":"10.1097\/md.0000000000036156","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:25:39Z","timestamp":1701163539000},"page":"e36156","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Gas therapy strategies for depression and schizophrenia: A review"],"prefix":"10.1097","volume":"102","author":[{"given":"Xun","family":"Tao","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Weifang Medical University, Weifang, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Weifang Medical University, Weifang, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Psychology, Weifang Medical University, Weifang Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Competency Training Center, Medical Experiment and Training Center, Weifang Medical University, Weifang Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Physical Education, School of Foundation Medical, Weifang Medical University, Weifang, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Psychology, Weifang Medical University, Weifang Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Li","sequence":"additional","affiliation":[{"name":"School of Psychology, Weifang Medical University, Weifang Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Technology, Weifang Medical University, Weifang, Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshuai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Technology, Weifang Medical University, Weifang, Shandong, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6920-3127","authenticated-orcid":false,"given":"Feng","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Practical Teaching Management Department, Weifang Medical University, Weifang Shandong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"1228","article-title":"Adverse reactions of antidepressant drugs and their application in patients with cardiovascular diseases.","volume":"45","author":"Tang","year":"2020","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia.","volume":"349","author":"Freedman","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?","volume":"16","author":"Mailman","year":"2010","journal-title":"Curr Pharm Des"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs.","volume":"200","author":"Peluso","year":"2012","journal-title":"Br J Psychiatry"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12888-016-1049-5","article-title":"Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.","volume":"16","author":"de Silva","year":"2016","journal-title":"BMC Psychiatr"},{"key":"R6-20250504","first-page":"410","article-title":"Metabolic issues in psychotic disorders with the focus on first-episode patients: a review.","volume":"25","author":"Britvic","year":"2013","journal-title":"Psychiatr Danub"},{"key":"R7-20250504","first-page":"679","article-title":"Nitric oxide and prostaglandin systems in the stimulation of hypothalamic-pituitary-adrenal axis by neurotransmitters and neurohormones.","volume":"55","author":"Bugajski","year":"2004","journal-title":"J Physiol Pharmacol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/B978-0-12-800254-4.00006-4","article-title":"Hippocampus and nitric oxide.","volume":"96","author":"Hu","year":"2014","journal-title":"Vitam Horm"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1054-3589(08)61091-1","article-title":"Nitric oxide and cGMP signaling.","volume":"34","author":"McDonald","year":"1995","journal-title":"Adv Pharmacol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrd3228","article-title":"The therapeutic potential of carbon monoxide.","volume":"9","author":"Motterlini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/meth.1999.0892","article-title":"Activation of soluble guanylate cyclase by carbon monoxide and nitric oxide: a mechanistic model.","volume":"19","author":"Sharma","year":"1999","journal-title":"Methods"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"901","DOI":"10.36076\/ppj.2009\/12\/901","article-title":"Hydrogen sulfide\u2019s involvement in modulating nociception.","volume":"12","author":"Smith","year":"2009","journal-title":"Pain Physician"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neures.2005.07.002","article-title":"Modulating effect of hydrogen sulfide on gamma-aminobutyric acid B receptor in recurrent febrile seizures in rats.","volume":"53","author":"Han","year":"2005","journal-title":"Neurosci Res"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1471-4159.2010.06580.x","article-title":"Hydrogen sulfide as a gasotransmitter.","volume":"113","author":"Gadalla","year":"2010","journal-title":"J Neurochem"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cca.2014.10.037","article-title":"Hydrogen sulfide in signaling pathways.","volume":"439","author":"Olas","year":"2015","journal-title":"Clin Chim Acta"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.","volume":"35","author":"Maes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nbd.2009.11.015","article-title":"Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.","volume":"37","author":"Loftis","year":"2010","journal-title":"Neurobiol Dis"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pnpbp.2012.07.013","article-title":"Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.","volume":"39","author":"Raffa","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/336385a0","article-title":"Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.","volume":"336","author":"Garthwaite","year":"1988","journal-title":"Nature"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1476-5381.1993.tb13796.x","article-title":"Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles.","volume":"110","author":"Babbedge","year":"1993","journal-title":"Br J Pharmacol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002139900316","article-title":"Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats.","volume":"149","author":"Yildiz","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1164\/ajrccm.152.5.7582301","article-title":"Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase.","volume":"152","author":"Griffiths","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2007.12.041","article-title":"Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor.","volume":"433","author":"Wang","year":"2008","journal-title":"Neurosci Lett"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals.","volume":"298 (Pt 2)","author":"Knowles","year":"1994","journal-title":"Biochem J"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0893-133X(98)00008-6","article-title":"Nitric oxide synthase inhibitors attenuate phencyclidine-induced disruption of prepulse inhibition.","volume":"19","author":"Wiley","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fphar.2015.00292","article-title":"Inducible nitric oxide inhibitors block NMDA antagonist-stimulated motoric behaviors and medial prefrontal cortical glutamate efflux.","volume":"6","author":"Bergstrom","year":"2015","journal-title":"Front Pharmacol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.pnpbp.2011.06.002","article-title":"Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.","volume":"35","author":"Pereira","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/026988119801200306","article-title":"The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test.","volume":"12","author":"Vale","year":"1998","journal-title":"J Psychopharmacol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0196-9781(01)00439-9","article-title":"Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain.","volume":"22","author":"Monzon","year":"2001","journal-title":"Peptides"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0091-3057(01)00487-7","article-title":"Comparison of N2O- and chlordiazepoxide-induced behaviors in the light\/dark exploration test.","volume":"68","author":"Li","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"e5135","DOI":"10.1590\/1414-431x20165135","article-title":"Activation of locus coeruleus heme oxygenase-carbon monoxide pathway promoted an anxiolytic-like effect in rats.","volume":"49","author":"Carvalho-Costa","year":"2016","journal-title":"Braz J Med Biol Res"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjp.0707224","article-title":"Recent developments in nitric oxide donor drugs.","volume":"151","author":"Miller","year":"2007","journal-title":"Br J Pharmacol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.niox.2017.05.002","article-title":"Acute and repeated exposure with the nitric oxide (NO) donor sodium nitroprusside (SNP) differentially modulate responses in a rat model of anxiety.","volume":"69","author":"Orfanidou","year":"2017","journal-title":"Nitric Oxide"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/JCP.0000000000001388","article-title":"Mononitrate Isosorbide as an adjunctive therapy in schizophrenia: a randomized controlled crossover trial.","volume":"41","author":"Guimaraes","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00213-013-3277-4","article-title":"Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice.","volume":"231","author":"Issy","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00213-015-4181-x","article-title":"The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.","volume":"233","author":"Trevlopoulou","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamapsychiatry.2013.1292","article-title":"Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial.","volume":"70","author":"Hallak","year":"2013","journal-title":"JAMA Psychiatr"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.pbb.2012.06.013","article-title":"Nitric oxide modulates apomorphine-induced recognition memory deficits in rats.","volume":"102","author":"Gourgiotis","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2003.08.051","article-title":"Oxidative damage in brains of mice treated with apomorphine and its oxidized derivative.","volume":"992","author":"Moreira","year":"2003","journal-title":"Brain Res"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.pnpbp.2009.05.010","article-title":"Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats.","volume":"33","author":"de Oliveira","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"297357","DOI":"10.1155\/2013\/297357","article-title":"Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction.","volume":"2013","author":"Godinez-Rubi","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/cvr\/28.4.494","article-title":"Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats.","volume":"28","author":"Boger","year":"1994","journal-title":"Cardiovasc Res"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF03348006","article-title":"Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man.","volume":"20","author":"Maccario","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0006-8993(00)02254-X","article-title":"Nitric oxide donor-induced increase in permeability of the blood-brain barrier.","volume":"866","author":"Mayhan","year":"2000","journal-title":"Brain Res"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pbb.2015.09.004","article-title":"The nitric oxide donor molsidomine induces anxiolytic-like behaviour in two different rat models of anxiety.","volume":"138","author":"Kalouda","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jnr.20889","article-title":"Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.","volume":"84","author":"Pitsikas","year":"2006","journal-title":"J Neurosci Res"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s007020200037","article-title":"Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice.","volume":"109","author":"Tutka","year":"2002","journal-title":"J Neural Transm (Vienna)"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(97)01428-3","article-title":"Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine.","volume":"341","author":"Meyer","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(01)01164-5","article-title":"Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.","volume":"426","author":"Pitsikas","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R51-20250504","first-page":"4701","article-title":"Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer.","volume":"61","author":"Pervin","year":"2001","journal-title":"Cancer Res"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00213-008-1200-1","article-title":"DETA\/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis.","volume":"200","author":"Hua","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2017.09.007","article-title":"Enhanced expression of heme oxygenase-1 in the locus coeruleus can be associated with anxiolytic-like effects.","volume":"336","author":"Cazuza","year":"2018","journal-title":"Behav Brain Res"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s12035-020-01914-5","article-title":"CORM-2-solid lipid nanoparticles maintain integrity of blood-spinal cord barrier after spinal cord injury in rats.","volume":"57","author":"Joshi","year":"2020","journal-title":"Mol Neurobiol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"104842","DOI":"10.1016\/j.neuint.2020.104842","article-title":"CORM-3 ameliorates neurodegeneration in the amygdala and improves depression- and anxiety-like behavior in a rat model of combined traumatic brain injury and hemorrhagic shock.","volume":"140","author":"Li","year":"2020","journal-title":"Neurochem Int"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"757417","DOI":"10.3389\/fphar.2021.757417","article-title":"Exogenous Carbon Monoxide produces rapid antidepressant- and anxiolytic-like effects.","volume":"12","author":"Luo","year":"2021","journal-title":"Front Pharmacol"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s12035-015-9212-4","article-title":"Hydrogen sulfide ameliorates homocysteine-induced Alzheimer\u2019s disease-like pathology, blood-brain barrier disruption, and synaptic disorder.","volume":"53","author":"Kamat","year":"2016","journal-title":"Mol Neurobiol"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/FBP.0b013e3283654258","article-title":"Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in behavioral models of depression and anxiety.","volume":"24","author":"Chen","year":"2013","journal-title":"Behav Pharmacol"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12017-018-8505-y","article-title":"Neuroprotective effect of hydrogen sulfide in hyperhomocysteinemia is mediated through antioxidant action involving Nrf2.","volume":"20","author":"Kumar","year":"2018","journal-title":"Neuromolecular Med"},{"key":"R60-20250504","first-page":"305","article-title":"Hydrogen sulfide ameliorates homocysteine-induced cognitive dysfunction by inhibition of reactive aldehydes involving upregulation of ALDH2.","volume":"20","author":"Li","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pbb.2010.04.006","article-title":"Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats.","volume":"96","author":"Gong","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuint.2010.11.010","article-title":"Hydrogen sulfide reduces mRNA and protein levels of beta-site amyloid precursor protein cleaving enzyme 1 in PC12 cells.","volume":"58","author":"Zhang","year":"2011","journal-title":"Neurochem Int"},{"key":"R63-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/occmed\/48.4.255","article-title":"Persistent cognitive and motor deficits following acute hydrogen sulphide poisoning.","volume":"48","author":"Schneider","year":"1998","journal-title":"Occup Med (Lond)"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2017.01.059","article-title":"Anxiolytic-like effect of hydrogen sulfide (H2S) in rats exposed and re-exposed to the elevated plus-maze and open field tests.","volume":"642","author":"Donatti","year":"2017","journal-title":"Neurosci Lett"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/FBP.0000000000000143","article-title":"Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in streptozotocin-induced diabetic rats through inhibition of hippocampal oxidative stress.","volume":"26","author":"Tang","year":"2015","journal-title":"Behav Pharmacol"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/14737175.2019.1668270","article-title":"Hydrogen sulfide: a target to modulate oxidative stress and neuroplasticity for the treatment of pathological anxiety.","volume":"20","author":"Chen","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1039\/C9FO00601J","article-title":"Garlic essential oil mediates acute and chronic mild stress-induced depression in rats via modulation of monoaminergic neurotransmission and brain-derived neurotrophic factor levels.","volume":"10","author":"Huang","year":"2019","journal-title":"Food Funct"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.jid.2019.03.1165","article-title":"Molecular hydrogen protects human melanocytes from oxidative stress by activating Nrf2 signaling.","volume":"140","author":"Fang","year":"2020","journal-title":"J Invest Dermatol"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"101950","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control.","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biol"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/bs.mie.2014.11.038","article-title":"Molecular hydrogen as a novel antioxidant: overview of the advantages of hydrogen for medical applications.","volume":"555","author":"Ohta","year":"2015","journal-title":"Methods Enzymol"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/antiox11112153","article-title":"Treatment with hydrogen-rich water improves the nociceptive and anxio-depressive-like behaviors associated with chronic inflammatory pain in mice.","volume":"11","author":"Coral-Perez","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"35468","DOI":"10.52965\/001c.35468","article-title":"Effects of hydrogen water and psychological treatment in a sample of women with panic disorder: a randomized and controlled clinical trial.","volume":"10","author":"Fernandez-Serrano","year":"2022","journal-title":"Health Psychol Res"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1038\/s41598-017-10362-6","article-title":"Molecular hydrogen increases resilience to stress in mice.","volume":"7","author":"Gao","year":"2017","journal-title":"Sci Rep"},{"key":"R74-20250504","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuropharm.2017.03.029","article-title":"Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice.","volume":"118","author":"Wen","year":"2017","journal-title":"Neuropharmacology"},{"key":"R75-20250504","doi-asserted-by":"crossref","first-page":"106585","DOI":"10.1016\/j.intimp.2020.106585","article-title":"Hydrogen gas alleviates blood-brain barrier impairment and cognitive dysfunction of septic mice in an Nrf2-dependent pathway.","volume":"85","author":"Yu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R76-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1179\/1743132812Y.0000000002","article-title":"Inhalation of hydrogen gas attenuates cognitive impairment in transient cerebral ischemia via inhibition of oxidative stress.","volume":"34","author":"Ge","year":"2012","journal-title":"Neurol Res"},{"key":"R77-20250504","first-page":"1162","article-title":"Hydrogen-rich saline attenuates isoflurane-induced caspase-3 activation and cognitive impairment via inhibition of isoflurane-induced oxidative stress, mitochondrial dysfunction, and reduction in ATP levels.","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res"},{"key":"R78-20250504","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijpharm.2017.05.051","article-title":"Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: physicochemical and in vivo performances.","volume":"533","author":"Dordevic","year":"2017","journal-title":"Int J Pharm"},{"key":"R79-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2015.07.007","article-title":"Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: design, characterization and in vivo pharmacokinetic evaluation.","volume":"493","author":"Dordevic","year":"2015","journal-title":"Int J Pharm"},{"key":"R80-20250504","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.euroneuro.2019.08.302","article-title":"Enhancement of the antipsychotic effect of risperidone by sodium nitroprusside in rats.","volume":"29","author":"Titulaer","year":"2019","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:03:37Z","timestamp":1746345817000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":80,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036156","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}